ANI Pharmaceuticals Inc (ANIP) financials · rev $883.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
ANI Pharmaceuticals Inc (ANIP) rev $883.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $883.4M | $614.4M |
| Operating Income | $111.1M | $584.0K |
| Net Income | $78.3M | -$18.5M |
| EPS (Diluted) | $3.32 | -$1.04 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.44B | $1.28B |
| Current Assets | $753.1M | $527.7M |
| Cash & Equivalents | $285.6M | $144.9M |
| Inventory | $143.1M | $136.8M |
| PP&E | $62.5M | $56.9M |
| Total Liabilities | $899.7M | $855.2M |
| Current Liabilities | $278.1M | $193.7M |
| Short-term Debt | $17.3M | $9.17M |
| Long-term Debt | $291.8M | $309.1M |
| Total Debt | $309.1M† | $318.3M† |
| Shareholders' Equity | $540.7M | $403.7M |
| Retained Earnings | -$23.1M | -$100.3M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $185.2M | $64.0M |
| CapEx | $13.8M | $16.2M |
| Investing Cash Flow | -$34.3M | -$404.7M |
| Financing Cash Flow | -$9.94M | $264.9M |
| Dividends Paid | $1.16M | $1.63M |
| Net Change in Cash | $140.7M | -$76.2M |
| Free Cash Flow | $171.4M | $47.8M |
FAQ
What is ANIP P/E and revenue?
ANI Pharmaceuticals Inc (ANIP) rev $883.4M.
What is ANIP revenue?
ANI Pharmaceuticals Inc last cached revenue is $883.4M (FY2025).
Is ANIP profitable?
ANI Pharmaceuticals Inc last cached net income is $78.3M (FY2025).
What are ANIP total assets?
ANI Pharmaceuticals Inc last cached total assets are $1.44B (FY2025).
What is ANIP free cash flow?
ANI Pharmaceuticals Inc last cached free cash flow is $171.4M (FY2025).
Not investment advice. Cached statements, not a live tape.